« Zurück
Home /
MOLM-13 cells

MOLM-13 cells

ArtNr	C0003003
Hersteller	Addexbio
Menge	One Frozen vial
Kategorie	Oncology Neuroscience Neural Lineage Markers Neuroinflammation Aging & Neurological Disorders Cell Lines & Cell Culture Cell Lines By Organ Heart & Blood Cancer
Typ	Tumour Cells
Specific against	Human (Homo sapiens)
Dry ice	Yes
Citations	1. Fang J et al. Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-?B gene network. Cell Rep. 2014;8(5):1328-1338. PMID:25199827 2. Qi W, Zhang W, Edwards H, Chu R, Madlambayan GJ, Taub JW, Wang Z, Wang Y, Li C, Lin H, Ge Y. Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo. Cancer Biol Ther. 2015;16(12):1784-1793. doi: 10.1080/15384047.2015.1095406. PMID:26529495 3. Montemurro, L., Tonelli, R., Fazzina, R., Martino, V., Marino, F., and Pession, A. Identification of two MLL-MLLT3 (alias MLL-AF9) chimeric transcripts in the MOLM-13 cell line. Cancer Genet Cytogenet, 154: 96-97, 2004. 4.Qi W, Xie C, Li C, Caldwell JT, Edwards H, Taub JW, Wang Y1, Lin H, Ge Y. CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells. J Hematol Oncol. 2014 Aug 1;7:53. PMID: 25084614 5. Luedtke DA, Niu X, Pan Y, Zhao J, Liu S, Edwards H, Chen K, Lin H, Taub JW, Ge Y. Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells. Signal Transduct Target Ther. 2017 Apr 7;2:17012. doi: 10.1038/sigtrans.2017.12. PMID: 29263915
ECLASS 10.1	32160890
ECLASS 11.0	32160890
UNSPSC	41106509
Lieferbar
Description	Disease: Acute myeloid leukemia (AML) Origin: Established from the peripheral blood Species: Homo sapiens Tissue: Blood Properties: Suspension Cytogenic data: Hyperdiploid karyotype Patient: Male, 20 yrs of age Medium: AddexBio-formulated RPMI-1640 Medium (C0004-01) + 20% FBS Subculture: Cultures can be maintained by the addition or replacement of fresh medium. Start new cultures at 1 X 10⁵ viable cells/ml. Subculture at 1 X 10⁶ cells/ml. Culture cells at 5% CO₂, 37C. Medium Renewal: Split saturated culture 1:2 to 1:3. Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 10; D13S317: 10, 11; D16S539: 10, 11; D5S818: 10, 11; D7S820: 10, 12; THO1: 7; TPOX: 8; vWA: 16, 17 Protein Expression: CD3 -, CD4 +, CD13 (+), CD14 -, CD15 +, CD19 -, CD33 +, CD34 -, cyCD68 +, HLA-DR - Mutations in MOLM-13 Cells Related cells by Organ: CCRF-CEM K562 LP-1 MOLM-13 RPMI-8226 U937 RAW 264.7
Storage condition	LN2
Manufacturers Category	Cell Lines

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkdatenblatt anfordern

C0003003-safety-datasheet.pdf